Abcam PLC Fundamentals Datasheet and Stock Analysis
Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company's purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways. The Company is engaged in data sharing and ecommerce in the life sciences. The Company focuses on helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. Two-thirds of the world's 750,000 life science researchers use its affinity binders, reagents, biomarkers and assays and the Company's products are mentioned in over 20,000 of the 56,000 peer-reviewed papers published each year in the life sciences. It has approximately 10 locations located in the world, through life science research hubs, enabling local services and multi-language support.
- Current Price:1,423.00p
- Industry:Health Care
- Sector:Health Care
- ISIN:GB00B6774699
- Market Sector:AIM
- Main Indices:FTSE AIM, FTSE AIM 50, FTSE AIM 100
- Country of register:Great Britain
- Currency:N/A
- Shares in Issue:227m
- Market Cap:£3,269m
- Date Listed:15/11/2010
Loading...
Activity Data Not Available
CEO: Alan Thomas Hirzel CFO: Michael Baldock Non-Executive Director: Giles Kerr, Mara G Aspinall, Bessie Lee Mark Capone Non-Executive Chairman: Peter Allen Senior Independent Director: Louise Patten
- Registrars:
- Address:Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom
- Phone:+44 (0)1223 696 000
- Website:http://www.abcam.com
2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Day/Month | 30/6 | 30/6 | 30/6 | 30/6 | 30/6 | 30/6 | 30/6 | 30/6 | 30/6 | ||
Revenue | £m | 122.21 | 127.95 | 144.03 | 171.67 | 217.10 | 233.20 | 259.90 | 260.00 | £m | 297.37 |
Operating Profit/(loss) | £m | 42.85 | 43.31 | 45.73 | 46.32 | 55.14 | 68.80 | 56.10 | 10.50 | £m | 0.00 |
Profit Before Tax | £m | 42.89 | 43.55 | 46.10 | 45.41 | 51.87 | 69.10 | 56.40 | 8.40 | £m | 48.09 |
Profit After Tax | £m | 32.66 | 34.04 | 37.38 | 37.43 | 42.36 | 62.20 | 45.00 | 12.50 | £m | 0.00 |
Profit After Tax (from discontinued operations) | £m | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | £m | 0.00 |
Overall Profit for the Period | £m | 32.66 | 34.04 | 37.38 | 37.43 | 42.36 | 62.20 | 45.00 | 12.50 | £m | 0.00 |
EPS Growth | % | 19.10 | 4.16 | 9.11 | (0.22) | 11.93 | 45.61 | (27.81) | (72.48) | % | 7.00 |
Earnings Per Share | p | 16.34 | 17.02 | 18.57 | 18.53 | 20.74 | 30.20 | 21.80 | 6.00 | p | 17.85 |
Op. Cash Flow P/S | p | 19.73 | 20.65 | 19.98 | 23.42 | 32.52 | 30.76 | 33.96 | 30.06 | £ | 0.00 |
Cash Flow P/S Grth | % | 534.41 | 4.66 | (3.24) | 17.22 | 38.86 | (5.41) | 10.40 | (11.48) | % | 0.00 |
Net Cash Flow P/S | p | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | £ | 0.00 |
Capital Exp P/S | £ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | £ | 0.00 |
Tax Rate | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | % | 0.00 |
P/E Ratio | x | 27.50 | 22.00 | 27.20 | 39.50 | 46.90 | 43.70 | 67.00 | 230.20 | x | 85.00 |
P/E Growth | £ | 0.00 | 0.00 | 0.00 | 0.00 | 2.70 | 1.50 | 73.30 | 0.00 | £ | 12.40 |
Turnover Per Share | £ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | £ | 0.00 |
Pre-Tax Profit / Share | £ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | £ | 0.00 |
Operating Margin | % | 35.06 | 33.85 | 31.75 | 26.98 | 25.40 | 29.50 | 21.59 | 4.04 | % | 0.00 |
ROCE | % | 23.55 | 22.83 | 20.14 | 15.33 | 16.80 | 20.61 | 14.05 | 1.52 | % | 0.00 |
ROE | % | 20.51 | 19.39 | 18.93 | 15.75 | 14.92 | 18.88 | 12.22 | 2.82 | % | 0.00 |
Mkt Cap | £m | 930.12 | 776.14 | 1,100.42 | 1,666.43 | 2,223.04 | 3,024.51 | 3,341.92 | 3,131.07 | £m | 0.00 |
Dividend Per Share | p | 7.04 | 7.75 | 8.21 | 8.91 | 10.18 | 12.00 | 12.13 | 3.55 | p | 0.82 |
DPS Growth | % | 0.00 | 0.00 | 0.00 | 0.00 | 14.25 | 17.88 | 1.08 | (70.73) | % | 0.00 |
Dividend Yield | % | 1.60 | 2.10 | 1.60 | 1.20 | 1.00 | 0.90 | 0.80 | 0.30 | % | 0.10 |
Dividend Cover | x | 2.52 | 2.34 | 2.42 | 2.52 | 2.52 | 2.73 | 2.71 | 4.70 | x | 0.00 |
Shareholder Funds | £m | 170.28 | 180.90 | 214.10 | 261.19 | 307.12 | 351.70 | 384.80 | 502.60 | £m | 0.00 |
Net Borrowings | £m | (35.39) | (55.28) | (57.06) | (68.92) | (84.75) | (90.20) | (87.10) | (187.30) | £m | 0.00 |
Net Assets | £m | 170.28 | 180.90 | 214.10 | 261.19 | 307.12 | 351.70 | 384.80 | 502.60 | £m | 0.00 |
Net Assets P/S | £ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | £ | 0.00 |
Latest | Forecast | |
---|---|---|
Div Yield | 0.3% | 0.1% |
Div Cover | 4.7% | 10.8% |
Op Margin | 4.0% | 15.3% |
ROCE | 2.5% |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
09-Mar-21 | Buy | Alan Thomas Hirzel | 1,485.69p | 2,500 | ,337,142.31 |
09-Mar-21 | Buy | Michael Baldock | 20.66$ | 5,000 | $85,181.83 |
03-Nov-20 | Sell | Alan Thomas Hirzel | 1,499.48p | 19,432 | £,291,378.76 |
17-Sep-20 | Buy | Peter Allen | 1,253.00p | 3,602 | ,345,133.06 |
17-Sep-20 | Buy | Mara G Aspinall | 1,253.00p | 1,623 | ,320,336.19 |
17-Sep-20 | Buy | Louise Patten | 1,253.00p | 1,126 | ,314,108.78 |
17-Sep-20 | Buy | Giles Kerr | 1,253.00p | 1,025 | ,312,843.25 |
17-Sep-20 | Buy | Jonathan Simon Milner | 1,253.00p | 953 | ,311,941.09 |
17-Apr-20 | Buy Dividends | Alan Thomas Hirzel | 1,124.00p | 19 | £,213.56 |
29-Nov-19 | Buy Dividends | Alan Thomas Hirzel | 1,326.00p | 39 | £,517.14 |
Notifier | Holding | Value |
---|---|---|
Alan Thomas Hirzel | 203,911 | ,887,379.76 |
Louise Patten | 54,842 | ̈,562.72 |
Peter Allen | 18,563 | Ć,852.08 |
Mara G Aspinall | 14,545 | Í,957.20 |
Michael Baldock | 5,000 | F,800 |
News Title | Date | Time | Source |
---|---|---|---|
Statement re Update on 2019 AGM Resolution Vote | 11-May-20 | 11:00 | RNS |
Total Voting Rights | 01-May-20 | 12:24 | RNS |
Holding(s) in Company | 22-Apr-20 | 10:11 | RNS |
Director/PDMR Shareholding | 21-Apr-20 | 07:26 | RNS |
Holding(s) in Company | 20-Apr-20 | 10:19 | RNS |
COVID-19 Update | 20-Apr-20 | 07:00 | RNS |
Holding(s) in Company | 14-Apr-20 | 10:07 | RNS |
Issue of Shares | 09-Apr-20 | 17:33 | RNS |
Total Voting Rights | 02-Apr-20 | 09:50 | RNS |
Holding(s) in Company | 27-Mar-20 | 15:37 | RNS |
Date | Broker Name | Rec | Price | Old Price Target | New Price Target | Broker Change |
---|---|---|---|---|---|---|
10-Mar-21 | Berenberg Bank | Hold | 1533.00p | 1180.00p | 1300.00p | Reiteration |
09-Mar-21 | JP Morgan Cazenove | Neutral | 1494.00p | 1400.00p | 1300.00p | Reiteration |
17-Dec-20 | Peel Hunt Limited | Hold | 1444.00p | 0.00p | 1530.00p | Reiteration |
12-Nov-19 | RBC Capital Markets | Sector perform | 1260.00p | 0.00p | 1300.00p | Reiteration |
11-Nov-19 | Liberum Capital | Hold | 1249.00p | 0.00p | 1230.00p | Reiteration |
08-Jan-19 | Numis | Add | 1208.80p | 1340.00p | 1340.00p | Upgrade |
18-Mar-15 | Investec Securities | Hold | 486.00p | 0.00p | 0.00p | DownGrade |
09-Mar-15 | N 1 Singer | Sell | 471.75p | 0.00p | 0.00p | Reiteration |
09-Mar-15 | Canaccord Genuity | Hold | 471.75p | 0.00p | 432.00p | Reiteration |
09-Mar-15 | Numis Securities | Buy | 472.75p | 580.00p | 580.00p | Reiteration |